Medicine and Dentistry
Acute Myeloid Leukemia
75%
B Cell
32%
Bcl-xL
25%
Biopsy
30%
Bladder
25%
Bone Marrow Biopsy
25%
Bone Metastasis
25%
Burkitt's Lymphoma
25%
Carbon 11
25%
Chemokine
25%
Choline
25%
Classical Hodgkin Lymphoma
50%
Diagnosis
55%
Diagnostic Performance
27%
Diffuse Large B-Cell Lymphoma
37%
Disease
36%
Epithelial Cell Adhesion Molecule
75%
First-in-Man Study
25%
Fluorodeoxyglucose F 18
47%
Follicular Lymphoma
25%
Gastrin Releasing Peptide Receptor
31%
Genetic Analysis
25%
Haemophilus influenzae
25%
Immune Disorder
25%
Immunoglobulin
54%
Immunohistochemistry
72%
Lymph Node Metastasis
50%
Lymphadenopathy
32%
Lymphoma Diagnostics
25%
Lymphoproliferative Disease
25%
Mantle Cell Lymphoma Cell
25%
Metastatic Carcinoma
30%
Morphology
25%
Multiple Myeloma
25%
Neck
25%
Necrosis
25%
Neoplasm
49%
Pediatrics
52%
Positron Emission Tomography
50%
Positron Emission Tomography-Computed Tomography
50%
Posttransplant Lymphoproliferative Disease
50%
Prostate Cancer
100%
Prostate Carcinoma
25%
Prostate Specific Membrane Antigen
25%
Radiation Therapy
25%
Stress Activated Protein Kinase Inhibitor
25%
Thymus
25%
Transitional Cell Carcinoma
25%
Vascularity
28%
Vasculotropin
78%
Keyphrases
Acute Leukemia
25%
Adhesion Molecules Expression
25%
Alemtuzumab
25%
Angiogenesis
6%
Angiogenic Factors
6%
Bone Marrow
6%
Bone Metastasis
25%
Cell Cycle Deregulation
25%
Cell Mobilization
25%
Complete Remission
6%
Cytomegalovirus Prophylaxis
25%
Endoreduplication
5%
Epithelial Cell Adhesion Molecule (EpCAM)
25%
First-in-man Study
25%
Growth Factor Receptor Signaling
6%
Imaging Target
7%
Immune Disorders
25%
Immunodeficiency
25%
Immunohistochemical Findings
8%
Intensive Care Medicine
6%
JAK2V617F
25%
JNK Inhibitor
25%
Leukemic Cells
6%
Lymph Node
10%
Lymph Node Metastasis
25%
Mature Lymphoid Neoplasms
7%
MiR-127
25%
MiR-17-5p
25%
MiR-19a
7%
Molecular mutations
25%
Neovascularization
6%
New Vessels
25%
Pediatric Nodal Marginal Zone Lymphoma
20%
Peripheral T-cell Lymphoma
25%
Prednisone Therapy
25%
Proliferation Centers
25%
Prostate Cancer Model
25%
Prostate Carcinoma
25%
Refractory Anaemia with Ring Sideroblasts
25%
Reoccurrence
6%
Single-center Analysis
25%
Therapy Protocols
6%
Transformed Follicular Lymphoma
25%
Vascular Endothelial Growth Factor
25%
Vascular Endothelial Growth Factor Expression
6%
Vascular Endothelial Growth Factor Receptor (VEGFR)
25%
Vascular Morphology
25%
Vasculogenesis
6%
Vessel Count
11%
Vessel Formation
25%
Immunology and Microbiology
Angiogenesis
6%
Angiogenic Factor
5%
B Cell
61%
Beta-2 Microglobulin
6%
C-Reactive Protein
18%
Cancer Cell
25%
CD23
8%
Cell Migration
8%
Cell Proliferation
8%
Cell Suspension
8%
Central Nervous System
25%
Chromosome Translocation
8%
Coculture
5%
Computer Assisted Tomography
10%
CXCR4
25%
Cyclin D1
8%
Epstein Barr Virus
28%
Event Free Survival
6%
Fluorescence in Situ Hybridization
8%
Gene Expression
25%
Gene Expression Profiling
8%
Germinal Center
34%
Immunoglobulin Heavy Chain
25%
in Situ Hybridization
12%
Interferon Regulatory Factor 4
8%
Interleukin-6
6%
Intravenous Immunoglobulin
25%
Leukemia Cell
8%
Lymph Node
25%
Lymphoproliferative Disorders
25%
Mouse
5%
Mouse Model
28%
Multiple Myeloma
25%
Myeloblast
8%
Myeloid
75%
Plasma Cell
12%
Plerixafor
25%
Positron Emission Tomography
25%
Positron Emission Tomography-Computed Tomography
25%
Progression Free Survival
7%
Prolymphocyte
5%
Protein Phosphorylation
8%
Quantitative Reverse Transcription Polymerase Chain Reaction
7%
Radioresistance
25%
STAT3
6%
Transplant Procedure
25%
Tumor Cell
12%
Vascularization
28%
Vasculotropin
28%
Xenograft
13%
